Discover Kymera Therapeutics' Q3 2025 earnings, clinical trial milestones in immunology, and strategic Gilead partnership.

New research reveals that men need twice as much exercise as women to prevent heart disease. The study shows that women ...

On-chain analysts can’t stop a crash, but by tracking capital movement, leverage, and sentiment, they can spot the storm ...

A new study details howPresident Trump's tariffs could make many things more expensive this holiday season. Here's a look at the Trump tariffs impact.

Identity resolution often anchors vendor pitches. Vendors claim CDPs can merge disparate identifiers into coherent customer ...

TG Therapeutics, Inc. posted a strong Q3 with soaring Briumvi sales and increased guidance. Click for my updated look at TGTX ...

This special report examines the controversy sparked by a new, non-peer-reviewed study from the METCOLOR Foundation involving ...

In the final days before the election, candidates around the country are putting rising electricity bills on center stage — ...

The Canadian Investment Regulatory Organization’s (CIRO) decision to abandon its retail client-data project is indefensible.

Stay up to date on the latest AI technology advancements and learn about the challenges and opportunities AI presents now and ...

Garg, recently named to BioSpace’s 40 Under 40, proved her mettle managing one of the toughest partnerships out there: the ...

There is no evidence that less frequent financial reporting impairs company performance, market functioning, or the quality of investor information.